top of page

2021 and Early 2022 Upcoming Biomedical Conferences


  • Biomedical conferences throughout the year include company presentations that may report significant clinical trial updates

  • These conferences each have specific deadlines and dates when presentation titles, abstracts, etc are available

  • Conference embargo policies can determine when stock changes are most likely to occur

  • For more specific information about conference deadlines and embargo policies, read our full article HERE after signing up. Learn more here.


Want to get Catalyst Events and stocks to watch sent directly to your inbox each week? sign up for our free weekly newsletter


At we follow over 500 biopharmaceutical companies and their 1500+ assets throughout clinical trials. Many of these companies present at one or multiple conferences throughout the year to report clinical trial data. Depending on the embargo policy for a conference, some biopharma stocks move significantly upon abstract release and as a result of presentations at the conference because they report important clinical trial updates.

Positive clinical trial results in a single trial can have a significant impact on the underlying stock price. This is especially true for biopharma companies with market caps under $5 billion, who typically have far less clinical and approved assets than larger companies, and thus whose valuation can be more affected by a single drug candidate and trial. The clinical assets of these micro, small and mid-cap cancer biopharma companies are a primary driver for the development of future drugs and therapies.

The remaining conferences for 2021 (and into early 2022) include conferences focusing on liver disease, kidney disease, breast cancer, immunology, and hematology. Table 1 shows these upcoming conferences, topics, and dates. We will be following these conferences closely and reporting data including companies involved and if they are presenting important new data (such as efficacy and safety data) as the conferences get closer. See our forum post HERE for important dates and embargo policies for each conference.

Table 1. Upcoming Conference Schedule


If you are serious about investing in biotech stocks BPIQ is the research companion that will take you to the next level.

Save yourself time by accessing our database of over 550 companies, 1,800+ of their drug assets, and tools including: Catalyst Calendar, Big Movers, Company Pipelines, and more!

P.S. We are currently running a sale - lock in the price before it's gone


See what our members are saying about us:

Mike from United States

“Really loving the site over the competitor... like the layout and speed over the the individual pages for each drug/treatment”

Carl from United States

“I like your service. I haven’t seen anyone else doing something similar...nothing like this available for retail.”

Essey from Canada

“Love what you’re doing, this website is awesome.”

James from United States

Great site and I see it’s a family run business, great job.”

bottom of page